300675SZSE

2025 Annual Report of Independent Director (Xie Lanjun)

✨ AI Summary

This report outlines the performance of Xie Lanjun as an independent director of Shenzhen Architectural Science Research Institute Co., Ltd. in 2025. It confirms compliance with independence requirements and details participation in board meetings, decision-making processes, and communication with shareholders. The report concludes that all actions taken were in the best interest of shareholders, particularly minority shareholders, with no dissenting opinions on board resolutions.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Securities Code: 300675

Securities Abbreviation: Jian Keyuan

Independent Director's Performance Report

Independent Director: Xie Lanjun

Dear shareholders and representatives:

As an independent director of Shenzhen Architectural Science Research Institute Co., Ltd. (hereinafter referred to as the "Company") in the fourth board of directors, I have strictly adhered to the relevant laws, regulations, and the Company’s articles of association in 2025. I have diligently fulfilled my responsibilities, maintained the independence and professionalism of the independent director role, and safeguarded the overall interests of the Company and the legitimate rights and interests of all shareholders, especially minority shareholders. Below is my report on the performance of my duties as an independent director in 2025.

Basic Information of the Independent Director

Work Experience, Professional Background, and Position: I, Xie Lanjun, born in 1966, am a member of the Communist Party of China with a bachelor's degree in law from Lanzhou University. I hold an independent director qualification certificate recognized by the Shenzhen Stock Exchange and am a Chinese national without permanent residency abroad. I began my career in 1989, working successively at various law firms and have been a partner and lawyer at Beijing Zhongyin (Shenzhen) Law Firm since September 2010. I have served as an independent director of the Company since November 2020 and was re-elected as an independent director by the shareholders' meeting in July 2024.

Independence Status

I have conducted a self-assessment regarding my independence in accordance with the relevant regulations and submitted a self-assessment report to the board (see attachment). The self-assessment confirms that I meet the independence requirements and that there are no factors affecting my independence.

Performance Overview of the Independent Director

Attendance at Board and Shareholder Meetings: In 2025, the board held 9 meetings, and I attended all of them without absence. I prepared thoroughly, reviewed each proposal, actively participated in discussions, and provided reasonable suggestions based on my expertise. I believe that all proposals did not harm the interests of shareholders, especially minority shareholders, and I exercised my voting rights with caution.

The Company held 3 shareholder meetings in 2025, and I attended all of them. I actively listened to questions and suggestions from attendees to better fulfill my duties as an independent director and promote the Company's standardized operations. I believe that all meetings were convened and conducted in accordance with legal procedures, and all significant operational decisions were made following the proper processes. I did not raise any objections to the proposals reviewed by the board in 2025 and voted in favor of all proposals without dissenting or abstaining votes.

Independent Opinions and Special Meetings: As an independent director, I diligently understood and verified the Company's operational activities. Based on my independent position, I expressed agreement with relevant board proposals and matters in collaboration with other independent directors or through special meetings. Specific details are provided in the attachment.

Performance in Board Committees and Special Meetings

I serve as the chair of the Nomination Committee and a member of the Audit Committee of the fourth board. In 2025, I attended 7 Audit Committee meetings, while the Nomination Committee did not convene. I also attended 1 special meeting for independent directors and participated in 1 meeting of the Compensation and Assessment Committee. I did not delegate my attendance to other independent directors and complied with the meeting rules and relevant regulations.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.